10:29 AM EDT, 05/15/2024 (MT Newswires) -- Microbix Biosystems Inc. ( MBXBF ) , a life sciences innovator, manufacturer, and exporter, was at last look up near 10% on Wednesday after it reported fiscal second-quarter net income and comprehensive income of $377,730, up from $31,616 a year earlier as revenues "led to meaningful net earnings and continue to set the stage for a record full-year fiscal 2024".

Total revenue for the quarter ended March 31 was $5.6 million, up 34% from $4.2 million a year earlier, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices businesses.

Looking ahead, Microbix said it will continue to drive sales growth across all of its business lines, and work to keep improving percentage gross margins and driving bottom-line results. The company currently expects to generate "meaningful" year-over-year growth in revenue and net earnings across the full-year fiscal 2024.

The company's shares were up more than 10% at last look on Wednesday.

Price: 0.35, Change: +0.03, Percent Change: +9.37